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Our main purpose is to compare classical nonself-centered, two-signal theoretical models
of the adaptive immune system with a novel, self-centered, one-signal model developed
by our research group. Our model hypothesizes that the immune system of a fetus is
capable learning the limited set of self antigens but unable to prepare itself for the
unlimited variety of nonself antigens. We have built a computational model that simulates
the development of the adaptive immune system. For simplicity, we concentrated on
humoral immunity and its major components: T cells, B cells, antibodies, interleukins,
non-immune self cells, and foreign antigens. Our model is a microscopic one, similar to the
interacting particle models of statistical physics and agent-based models in immunology.
Furthermore, our model is stochastic: events are considered random and modeled by a
continuous time, finite state Markov process, that is, they are controlled by finitely many
independent exponential clocks.
The simulation begins after conception, develops the immune system from scratch
and learns the set of self antigens. The simulation ends several months after birth when a
more-or-less stationary state of the immune system has been established. We investigate
how the immune system can recognize and fight against a primary infection. We also
investigate under what conditions can an immune memory be created that results in a
more effective immune response to a repeated infection. The simulations show that our
self-centered model is realistic. Moreover, in case of a primary adaptive immune reaction,
it can destroy infections more efficiently than a classical nonself-centered model.
Predictions of our theoretical model were clinically supported by autoimmune-related
adverse events in high-dose immune checkpoint inhibitor immunotherapy trials and also
by safe and successful low-dose immune checkpoint inhibitor combination treatment of
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heavily pretreated stage IV cancer patients who had exhausted all conventional treat-
ments. The MiStImm simulation tool and source codes are available at the address
https://github.com/kerepesi/MiStImm.
Keywords: immune system simulation, self-centered model
1. Introduction
1.1. Motivation of our work
The vast majority of published papers still portray the immune system with many
idealizations that neglect important epidemiologic observations and experimental
data at the expense of biological commonsense, see Section 1.1 in Ref. 1. For exam-
ple, the accepted dogma still claims that the evolution of the immune system was
driven by pathogens and a clonally based immune system is capable of efficiently
fighting primary bacterial or viral infections. Several observations, however, cannot
be reconciled with such assumptions.
US (Table 3 in Ref. 2) and Hungarian3,4 records from 1900 and 1896, respec-
tively, before the dramatic medical advances, show 32% and 27% deaths attributable
to infections, whereas only 5% and 2% due to cancer. The situation is similar even
nowadays in the case of low income countries.5 These data demonstrate that the
immune system is far from being infallible against pathogens. In contrast, the low
cancer incidence can be interpreted to mean that the immune system primarily
evolved to “maintain individual integrity in the midst of chaotic communal living”6
and just sequentially to cope with pathogens.
Considering the historical low death rate from cancers versus the high death rate
from infections, furthermore, the very slow proliferation of cancer cells versus the
explosive replication speed of pathogens, we argued for a self-centered model as the
explanation for T cell activation versus tolerance; see the long history of this view
of the immune system in Ref. 7. Based on information theoretical principles and the
law of parsimony we suggested that the ability of the immune system to recognize
all kinds of self antigens is sufficient to attack any nonself antigen.1,8–10 In order to
discriminate self and nonself, a relatively large fraction of T lymphocytes – the set
of regulatory T cells (Treg cells) – should primarily recognize the much smaller and
always available set of self antigens, rather than the practically unlimited and for
the immune system only partially known nonself antigen universe. In our model,
the role of regulatory T Cells (Foxp3+ Tregs) seems to be the closest analogy to
the role of homeostatic T cells.
Predictions of our theoretical model were supported by numerous clinical trial
observations. Immunotherapy has become a very promising approach to treat cancer
in the last few years. However, the developers of the inhibitory anti-CTLA-4 anti-
body started with the premise that a CTLA-4 (cytotoxic T lymphocyte-associated
antigen 4) blockade would selectively target T cells involved in the anti-tumor im-
mune response.11 Although the anti-CTLA-4 antibody improved survival in a mi-
nority of metastatic melanoma patients, the vast majority suffered autoimmune-
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related adverse events (irAEs).12
While the conventional nonself-centered, two-signal T cell activation models are
unable to explain the widespread and dose-dependent irAEs, our self-centered, one-
signal T cell activation theory can.10 The reason for this that tolerance mechanisms
of the nonself-centered, two-signal models eliminate self-reactive immune cells to
ensure that signal one can only originate from a foreign/mutated antigen. Immune
cells, however, require cognate receptor engagement with ubiquitous self antigens
in their ‘flight for survival’.13 Our model, therefore, predicted that a large ratio of
T cells should be temporarily activated by self antigens thus expressing CTLA-4
receptors that can be engaged by anti-CTLA-4 antibodies. It is consistent with the
immunological homunculus concept of Irun Cohen, who suggested that the immune
system continuously responds to self.14
Nothwithstanding, prolonged overstimulation of T cells by antibodies that tar-
get their negative regulators (immune checkpoint, IC) such as CTLA-4 and the
programmed cell death protein 1 pathway (PD-1/PD-L1) led to a breakthrough in
the treatment of a variety of malignancies. Although three generations of IC im-
munotherapy have been developed since Ref. 15, 16, the safety of IC blockade is still
an unresolved, timely and sensitive issue in the context of advanced cancer patients.
Based on our self-centered, one-signal theory, we have addressed the controversy
regarding the safety–efficacy issue in certain immunotherapy trials and argued that
the price we pay for reversing immunosuppression in cancer by a prolonged immune
checkpoint blockade is the generation of uncontrolled T-cell activation.17–20 In fact,
we predicted that harnessing the unleashed autoimmune power of T cells by low
dose IC blockade could be rewarding to defeat cancer. Using our prediction, Ref. 21
have developed just such a promising combination therapy, which was safely and
successfully administered to heavily pretreated stage IV cancer patients who had
exhausted all conventional treatments.
1.2. Theoretical and computational models
In a wide class of theoretical models22,23 even a primary immune reaction depends
on the recognition of nonself antigens by T and B cell receptors, so the theory
is nonself-centered. The role of self in those models is that the great majority of
autoreactive T and B cell clones are selected and purged from the immune system.24
For brevity, such theoretical models will be called Conventional Role of Self models
(CRS models) in the sequel.
On the other hand, a smaller class of theoretical models is based on the assump-
tion that recognizing and preserving self is the primary task of the immune system;
these are the self-centered models.7 Our group’s theoretical model belongs to the
class of self-centered models. It hypothesizes that the immune system of a fetus can
primarily learn what self is but is unable to prepare itself for the huge, unknown
variety of nonself. Consequently, a primary reaction against a nonself antigen is pos-
sible just by recognizing that the new antigen is not self. The assumed intrauterine
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learning process results in a repertoire of regulatory T cells (Tregs) that plays a
fundamental role: the set of Tregs keeps the immune image of the set of self anti-
gens during whole life and so – beside defending self from autoimmune reactions,
as in conventional models – directs immune reactions against nonself. Our theory
will be called Enhanced Role of Self model (ERS model) from now on.
Similar (but not identical) to our model is the mathematical model of T cell
mediated suppression of Ref. 25, where tolerance is also based on ubiquitous and
constitutive self-antigens, which select and sustain clones of specific regulatory (R)
cells, and which are similar to our Treg cells. In their model R cell populations
represent typically between 30% and 95% of the total T cells in the periphery.
It is an important difference to the widely accepted view in which conventional
regulatory CD4+CD25+ T cells (Treg) usually make up only about 5%–10% of
CD4+ T cells.26 R cells perform their function through linked recognition of the
APCs (antigen presenting cells). Also in their model, immune responses to foreign
antigens are achieved by displacing the self-antigens from the APCs, leading to a
loss of R cells if the foreign antigen introduction entails a sharp increase in the
number of foreign antigen carrying APCs.
Further, our intention was to create a computational model as well to show that
the ERS conceptual model is able to work in silico as is expected from the immune
system. Moreover, we wanted to show that the ERS model performs better than
CRS models in silico.
Table 1 in Ref. 27 broadly classifies computational models in immunology into
four groups: (1) individual particle-based stochastic, (2) particle number stochastic,
(3) concentration-based spatial non-stochastic, (4) concentration-based non-spatial
non-stochastic (see 330 references therein). A very broad class of computational
models uses ordinary differential equations and belongs to (3) or (4). Another wide
model classes are the cellular automata and agent-based models, belonging to (1)
or (2). Our computational model is in part individual particle based and in part
particle number stochastic, (1) and (2) combined. Essentially, we employed the ideas
of agent based models, though we used exclusively our own software.
A great advantage of such a model is that it can easily incorporate the most
important types of cells and molecules together with their essential features and
events that play important roles in immune reactions. In such a model events –
for example interactions of components – occur at random. Also, such a model is
typically microscopic in space and limited to a small variety of cells and molecules.
A stochastic model fits well with the affinity maturation of B lymphocytes in
which random events are perhaps the most characteristic. It is also suitable to model
the development of the regulatory T cell population and the random selection of
specific T cell clones. A major advantage of this approach is that it permits studying
random variations in the immune process.
To simplify things, we chose the humoral adaptive immune system as the first
modeling objective, since the humoral phase (blood or lymph) may be considered
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spatially homogeneous; thus a microscopic spatial volume may represent the whole
phase well. A major advantage of this approach is that it is not necessary to de-
scribe the actual spatial positions and spatial motions in the model. Instead, model
components randomly choose one of the other components as interaction partners,
because any components are close enough to become engaged in an interaction.
In sum, the novelty of the present paper is partly our ERS model which is a
specific self-centered conceptual immune model and partly the MiStImm compu-
tational model that we have developed to compare different theoretical models in
silico. The main research question of our work is to decide in silico if the ERS model
is feasible and it is able to fight against infections; moreover, whether it can fight
more efficiently than CRS models.
1.3. Some related conceptual and computational models
Important precursors to our work, using self-centered stance, were several models
by I.R. Cohen and coworkers.28–32
To our best knowledge, the first experiments with a detailed agent-based model
(IMMSIM) of immune system were.33–35 Their goal was to capture the dynamics
of the immune system and to perform experiments in silico. Later they studied the
thymus, the regulation of positive and negative selection, and the dynamics of the
production of the TCR repertoire in the thymus.36 Computational models mainly
based on the idea developed by Celada and Seiden have been also used in cancer
immunology; a review is in Ref. 37.
A closely related agent-based model, the C-ImmSim package has been developed
and investigated in Ref. 38. Later it was modified by Rapin et al; an excellent recent
description of their work can be found in Ref. 39. Their model represents pathogens,
as well as lymphocytes receptors, by means of their amino acid sequences and makes
use of bioinformatics methods for T and B cell epitope prediction. This is a key step
for their simulation of the immune response, because it determines immunogenicity.
The related book40 can be used as a practical guide to implement a computational
model with which one can study a specific disease.
The Basic Immune Simulator (BIS)41 is also an agent-based computing model
to study the interactions between innate and adaptive immunity. The BIS was
created using the Recursive Porus Agent Simulation Toolkit (RepastJ) library, an
open-source software library that is available online.42
Ref. 43 have developed SIMISYS, which is also a cellular automata model of the
human immune system. It uses tens of thousands of cells and innate and adaptive
components of the immune system. In particular, the model contains macrophages,
dendritic cells, neutrophils, natural killer cells, B cells, T helper cells, complement
proteins, and pathogenic bacteria.
Ref. 44 investigates a hypothesis about B cell hypermutation and affinity mat-
uration using both individual particle based stochastic and concentration-based
non-spatial non-stochastic, ordinary differential equation models.
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Finally, we mention an important recent book about immune system mod-
elling.45 In particular, a B cell model is developed in Ref. 46; the model has partly
similar ideas as our B cell model, but differs from ours in the representation of
ligands. Ligands in their model are encoded by bit strings and their distances are
measured by the number of mismatches (Hamming distance). It can be mentioned
that this kind of representation of ligands has appeared in many earlier models like
IMMSIM and C-ImmSim as well.
2. The ERS theoretical model
As was mentioned, our ERS model belongs to the class of self-centered models. Here
we describe the major aspects of our model.
2.1. A single T cell cannot discriminate self and nonself, only a
wide Treg repertoire can
Shapes of self and nonself entities are intricately interwoven sets; in the language of
the shape space model, the subsets of points representing self and nonself are com-
plexly interlaced and cannot be separated by a nice smooth mathematical curve.
Therefore the complexity of the antigen universe exceeds the capacity of an indi-
vidual T cell. The “knowledge” of each specific T cell is reflected by the shape of its
TCR. An individual T cell therefore is able to recognize only a set of complemen-
tary or near complementary MHC-peptide molecule. In the present paper T cells
with nearly complementary TCR to self-MHC-peptide complexes are designated as
regulatory T cells, Treg cells.47
In particular, the complete repertoire of Treg cells is able to reflect the whole set
of self antigens (See Ref. 1 and Fig. 1 and video animation in Ref. 10). The repertoire
of Tregs is first created in the thymus of the fetus by negative and positive selection
and it constitutes the basis for self–nonself discrimination. Any self-MHC-peptide
complex that is able to attach to a Treg with intermediate affinity can be classified
as self ; any other MHC-peptide complexes – that has weak affinity to each Treg but
may have strong affinity to one of the T cells – can be classified as nonself. Thus
the Treg repertoire – like the conductor of an orchestra – controls other elements
of the adaptive immune system. This does not exclude the possibility that Tregs –
like players of an orchestra – may take part in immune reactions similarly to other
conventional T cells as well. See further details in Ref. 1. After birth, development
of infection specific T cell and B cell clones are under Treg control.
Treg cells turn off antibody production and suppress the immune response. The
details of Treg cells functioning are still debated.48,49 For example, it is not clear
whether Treg cells can directly suppress B cells or whether they must suppress
Th cells in order to suppress B cells. Similarly as in Ref. 50, we model the direct
suppression of B cells, which has been suggested in a number of recent studies, see
e.g. Ref 51, 52.
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2.2. Different T cell – B cell interactions
As in our current computational model T cell – B cell interactions are basic, here
we describe three different types of it. Each of the three types fulfills an important
role in the ERS model (Fig. 1). Typical CRS models can be described by the third
type of interactions alone.
In a healthy individual during intrauterine life, randomly produced moderately
self-reactive B cell clones are confronted with an overwhelming quantity of soluble
self antigens. Those B cells that can attach with intermediate affinity to any of
these self antigens via their B cell receptors (BCRs) will present self peptides in
their surface major histocompatibility complex II (MHCII) molecules to regulatory
T helper cells (Thregs). This ensures B cell and Threg cell survival, respectively,
but it is insufficient to trigger extensive clonally based B cell expansion required for
specific immunity or autoimmunity. It will be called weak affinity interaction and
division from now on. Thus the positively selected Threg cells are critical parts of
the homeostatic control in our model, so that Threg clones exist for practically all
kinds of self-MHCII – self-peptide complexes presented by any of the B cells. After
birth, this process maintains an immune image of soluble self which can control
self–nonself discrimination.
During a primary infection a new antigen appears in the blood. B cells with
appropriate affinity for the new antigen, engulf new antigens and present its for-
eign peptides on their surface MHCII proteins. Since in our model foreign peptides
transiently inhibit the complementary TCR-MHC interactions, such perturbation
creates steric hindrance that obstructs the docking of positively selected Thregs.
Disruption of such contact between an MHCII and Thregs for a critical period of
time results in an emergency and activates the corresponding B cell. In order to
reestablish contact, foreign peptide presenting B cells will secrete chemotactic dan-
ger signals (“smoking gun”) attracting Th cells to this region. The B7-1 and B7-2
ligands of B cells will activate most CD28 receptors of the bystander helper T cells.
This initiates a non-specific, polyclonal activation in local Th lymphocytes via the
CD28 receptor alone53 such that a local cytokine storm is generated in Th cells
triggering B cells to clonal expansion, hypermutation, and eventually they may de-
velop into specific antibody producing plasma cells. This will be called intermediate
affinity interaction and division from now on. The resulting inner state of the af-
fected Th and B cells will be called “activated” state. Since affinity maturation is
driven by the fast increasing local concentration of pathogen antigens (e.g. hepatitis
virus), the probability of clonal autoimmunity is very low but possible.
The default mode of our model is that a random peptide decreases complemen-
tarity between a na¨ıve TCR and the MHC. However, following the initial polyclonal
activation phase, there is always a possibility that rare T cell and B cell clones with
higher affinity may well recognize foreign antigens, particularly when a significant
fraction of host cells is infected and viral load is high (for example in hepatitis,
see in Ref. 54). Such higher affinity interactions would then drive clonal (e.g. HCV
August 20, 2018 14:11 WSPC/INSTRUCTION FILE Mistimm
8 Szabados, Kerepesi, Baka´cs
Fig. 1. Humoral adaptive immune response. The ERS model is described by (a), (b) and
(c), while CRS models are described by (c) alone. In the ERS model, weak affinity interaction
(a) begins in intrauterin life and keeps the immune image of self during whole life. Also in the
ERS model, intermediate affinity interaction (b) is the initial phase of a primary infection. Strong
affinity interaction (specific immune reaction) (c) appears in both the ERS and CRS models and
usually needs several days to efficiently start. Signal strength (irrespective whether it comes via
one or two receptors) determines the outcome of B cell activation and/or clonal expansion. Weak
affinity interaction (a) is sufficient just for homeostasis; low affinity BCR binds self-antigens and
presents self-peptides in MHCII to regulatory T helper (Threg) cells; this ensures B and Threg
cell survival. Intermediate affinity interaction (b) is required for eradicating primary infections;
some B cells that have higher BCR affinity for the antigens of the pathogen than that of the host
will capture pathogens with intermediate affinity and present pathogen derived foreign peptides
in MHCII. The foreign peptides inhibit binding of Threg cells to these B cells for a critical time
period, then the latter will secrete soluble danger signals. Danger signals activate local Th cells,
which in turn, release interleukins that fuel local T cell activation, both helper and cytotoxic T
cells. Eventually a local cytokine storm is generated. This way a non-specific, local polyclonal B
and T cell activation is induced, which is the defense mechanism against primary infections in the
ERS model. Clonal expansion requires affinity maturation, which results in a several magnitude
increase of BCR affinity, typically over a time of one week. Random mutations cause the production
of B cells with a broad range of affinities for their antigen. B cells with unfavorable mutations will
not get sufficiently activated by the antigen and will die, while those with improved affinity will
be stimulated to clone themselves. This leads to an effective affinity-dependent selection process.
Strong affinity interaction (c) in the ERS and CRS models, in contrast, is supervised and supported
by pathogen peptide specific Th cells, which require direct contact via TCR to the MHCII of the
expanding B cell clone. This process is significantly slower than (b).
specific) T cell proliferation, activation, lysis of infected cells, as described by the
conventional two-signal models. Having cleared the infection, specific T cells could
eventually become an expanded memory type T cell clone, while B cells could differ-
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entiate into infection specific antibody producing plasma cells or memory B cells. It
is thought that acquisition of memory T cell function is an irreversible differentiation
event. Unlike regulatory T cells, such population does not require self-peptide–MHC
complexes for maintenance. Nevertheless, sustaining the functional phenotype of T
memory cells requires active signaling via CD27.55 Specific T and B cell activation,
proliferation and lysis of infected cells, therefore, obey the rules of the conventional
two-signal model. Clearly, this process may require several days in general. It will
be called strong interaction and division in the sequel. The resulting inner state of
the affected Th and B cells will be called “strongly activated” state.
3. Description of the MiStImm computational model
We made an effort to realize the above-mentioned ERS conceptual model in a
computational model as accurately as possible. The ERS theoretical model implies
that the immune system is a complex system; consequently, our computational
model has to be a complex model as well. We tried to stick to experimental facts
and pure logic as much as possible. Notwithstanding, we have to admit that several
authors are sceptic about such complex models of immune dynamics, see e.g. Ref. 56.
On the other hand, Ref. 57 convincingly argue that the immune system is a complex
system, thus a “minimal model” like Ref. 58 cannot describe the behavior of immune
system correctly.
We call our in silico model Microscopic Stochastic Immune model or briefly
MiStImm model. It is a further developed version of our 1994-98 B cell model.59
Our software is a C program and it was written in the spirit of the agent-based
models.
3.1. Mathematical model
Mathematically, the interactions of the components and other events in the model
are described by a continuous time, finite state, time-homogeneous Markov process,
see e.g. Ref. 60. A Markov process is a memoryless stochastic process: if we specify
the present state of the system, then we may forget about its history when we want
to investigate its behavior in the future.
More precisely, if the possible states of the system are denoted by the natural
numbers 1, 2, . . . ,M , and Xt is the random state of the process at time t ≥ 0, then
the process is described by the transition probabilities
Pi,j(t) = P(Xt+s = j | Xs = i) (i, j = 1, . . . ,M ; s, t ≥ 0).
Let P(t) = [Pi,j(t)]
M
i,j=1 and suppose that P(0) = I and limt→0+ P(t) = I, where I
is the identity matrix. Then it is well-known that
P(t) = eQt = I + Qt+
1
2
Q2t2 + · · · , Q = [qi,j ]Mi,j=1,
where Q is the infinitesimal generator of the Markov process. Thus
Pi,j(t) = δi,j + qi,j t+ o(t) as t→ 0+, (3.3)
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where δi,j = 1 if i = j and 0 otherwise, and o(t)/t→ 0. It means that the probability
of a transition from state i to a state j 6= i is determined by the rate qi,j ≥ 0;
qi,i = −
∑
j 6=i qi,j .
Let us recall that when one has a Markov transition probability
Pi,i+1(t) = qt+ o(t), Pi,i(t) = 1− qt− o(t) as t→ 0+,
then dividing the time interval [0, t] into n equal subintervals, it follows for the
corresponding Markov process Yt when Y0 = 0 that
P(Yt = k) = lim
n→∞
(
n
k
)(
qt
n
+ o
(
t
n
))k (
1− qt
n
− o
(
t
n
))n−k
= e−qt
(qt)k
k!
(t ≥ 0, k = 0, 1, 2, . . . ).
Thus Yt is a Poisson process, and so the holding time T := inf{t ≥ 0 : Yt 6= 0}
is exponentially distributed :
P(T ≥ t) = e−qt (t ≥ 0).
Hence it follows from (3.3), that if Xs = i, the holding time Ti := inf{t ≥ 0 :
Xs+t 6= i} is also exponentially distributed:
P(Ti ≥ t) = e−Qit (t ≥ 0), Qi :=
∑
j 6=i
qi,j = −qi,i. (3.8)
Thus one can realize the Markov process (Xt)t≥0 by assigning to any potential
random event an independent exponential clock with rate qi,j (j 6= i), supposing
that the present state of the system is Xs = i. When the first clock rings, say, the
jth one, the corresponding event, that is, the change from state i to j, occurs with
rate qi,j .
The simulation uses the well-known fact that when there are independent ex-
ponential clocks with rates qi,j (j 6= i), then the fastest event has also exponential
clock with rate Qi :=
∑
j 6=i qi,j , see (3.8). So at any step, it is enough to generate
a single exponential random number with rate Qi. Also, the probability that the
event j has occurred, is equal to qi,j/Qi (j 6= i), whose sum is 1. Thus one gener-
ates a uniform random number in [0, 1), and its value determines which one of the
concurrent events has occurred.
Our model has finitely many components at any time t: helper T cells (regulatory
Th cells and potential infection specific Th cells), B cells, antibodies, interleukins,
non-immune self cells, and foreign antigens. Presently, other than helper type T
cells or other antigen presenting cells besides B cells are not represented in our
computational model. Each component has a number of characteristics (parame-
ters) and certain attached random events or processes of events that may occur at
random. A potential event can be, for example, a division of a cell or an interaction
of a component with a randomly chosen partner. The occurrence of such an event
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may cause several changes in the model, like births, deaths, and updates of param-
eters. Because of the births and deaths, our mathematical model is somewhat more
general than the simple Markov model described above: the size M of the system
changes with time in general. However, it does not cause much difference. We set
the model parameters so that explosion does not occur and hence the number of po-
tential events remain finite for all t. At any step, one has to establish the number of
independent exponential clocks M(s), and determine their actual rates qi,j = 1/τi,j
(1 ≤ j ≤ M(s), j 6= i), where τi,j is the mean holding time of the jth component.
Then the simulation starts again with the new settings.
3.2. Basics
Peptide lattice Our computational model takes a microscopic volume of the hu-
moral phase and also a microscopically small part of the shape space universe. Shape
space models were used by Perelson, Segel and their colleagues since the 1970’s61,62
and also in the Celada–Seiden models mentioned above. To explain what we mean
by shape space here, assume that the shape of a T cell receptor (TCR) can be rep-
resented by a point in a large set of a Euclidean space. Theoretical considerations
compared with experimental data led to the conclusion61 that the dimension of this
shape space, i.e. the number of parameters essential in describing a binding, is not
too large, probably around five.
The microscopically small part of the shape space that we consider in our model
is a small discrete N ×N planar grid in the shape space (e.g. N = 1000). The x ∈
{0, 1, . . . , N} coordinate of a shape point may represent a “horizontal” coordinate of
the main part of the binding profile of a TCR or an MHC+peptide complex, while
the y ∈ {−N/2, . . . , N/2} coordinate may represent the “vertical” coordinate of
the main part of the binding profile. A positive coordinate represents “convexity”,
while a negative coordinate represents “concavity”. Fig. 2A shows our underlying
idea for the shape of a peptide characterized by a single point (xP , yP ). Needless
to say that our model of shapes is a much simplified one, but is still suitable to
represent essential binding properties of antigens. We call the above finite square
grid the peptide lattice in the sequel.
Antigen lattice Shape of a B cell receptor (BCR) or shape of an antigen is sim-
ilarly represented by a point of an antigen lattice in the model. Here again the
x ∈ {0, 1, . . . , N} coordinate of a shape point may represent a “horizontal” coor-
dinate of the main part of the binding profile of the BCR or antigen, while the
y ∈ {−N/2, . . . , N/2} coordinate may represent the “vertical” coordinate of the
main part of the binding profile; a positive coordinate representing “convexity”,
while a negative coordinate representing “concavity”, see Fig. 2A.
For simplicity, to each antigen (xA, yA) in the antigen lattice we assign exactly
one peptide (xP , yP ) in the peptide lattice. To make identification of an antigen
and its corresponding peptide easier, we will use the convention that xA = xP and
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Fig. 2. Figures of the mathematical model. (A) Shape space. Two simplified complementary
shapes characterized by the points (xP , yP ) and (xP ,−yP ), respectively, in the peptide lattice.
(B) Simplified graphical representation of the difference between the ERS and the CRS models.
Dark green: area allocated to regulatory T cells; light green: area for potential infection specific T
cells. (C) Two examples of a logistic function.
yA = yP .
Complementarity Complementarity plays a basic role in binding. The perfect
fit between a TCR and an MHC+peptide complex means in the model that the
shape (xT , yT ) of the TCR and the shape (xP , yP ) of the MHC+peptide satisfy the
equalities xT = xP and yT = −yP , see Fig. 2A. In the model we introduce a metric
or distance d to measure the degree of similarity of two shapes z1 := (x1, y1) and
z2 := (x2, y2):
d(z1, z2) := max{|x2 − x1|, |y2 − y1|}.
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A TCR zT := (xT , yT ) and an MHC+peptide zP := (xP , yP ) are nearly comple-
mentary in our model if the distance between zT and zP := (xP ,−yP ) is small
enough. Similar is the representation of the complementarity between BCRs and
antigens in the model.
Only complementary or nearly complementary shaped ligands and receptors
can bind. The dots in Fig. 2B represent TCRs that are exactly complementary to
some self MHC+self-peptide complex. The areas shaded in darker green are called
the characteristic rings of self-peptides. They represent the set of shapes that are
allocated to possible regulatory T cells after negative and positive selection in the
ERS model, see below. The areas denoted by lighter green correspond to possible
shapes of classical, potentially infection (or mutation) specific T cells, while white
areas are representing self-reactive T cells that are prohibited for T cells in the
two respective models. Observe that in the ERS model, moderately self-reactive
T cells are present after negative and positive selection. In fact, they constitute
the most important class of T cells that decide self–nonself discrimination. On the
other hand, such moderately self-reactive T cells are negatively selected out in CRS
models.
We mention that with the above metric, “circles” are in fact squares in our shape
space model.
A logistic function In biology it is typical that when the size of a certain cell
population gets larger the per capita birth rate in the population decreases. Thus
the size of a population first increases fast, later it slows down, and at the end it
gets relatively stable. So to control birth rates and other quantities we use a class of
logistic functions, previously applied by many other authors (see e.g. Ref. 63, 64):
gθ,η(x) :=
θη
θη + xη
=
(
1 +
(x
θ
)η)−1
(x ≥ 0; θ > 0, η > 0). (3.10)
This formula describes a decreasing function which is equal to 1 for x = 0, 1/2 for
the threshold value x = θ, and goes to 0 as x → ∞, see Fig. 2C. Its parameters
θ and η are set from case to case. We set the model parameters so that explosion
does not occur. In fact, the number of components should always remain in the
biologically feasible domain.
3.3. Self cells
At time zero, there is a number (say, 3) of different types of non-immune self cells
(briefly: self cells), each with a given initial population size (e.g. 150). A certain
type of self cells is represented by its position (xS , yS) in the antigen lattice and its
peptide (xP , yP ) in the peptide lattice. Specifically, there is a population of bone
marrow cells, handled separately from other self cells, with a given initial population
size.
Each type of self cells comes with a birth process with a given initial rate (that
is, with a given initial average waiting time τs0 between divisions). If the size of the
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population of a specific self cell at a certain time t is s = s(t), then the conditional
expected waiting between two divisions in this population is
τs =
τs0
s gθ,η(s)
=
τs0
s
(
1 +
(s
θ
)η)
, (η > 1). (3.11)
Formula (3.11) indicates that when the number s of a type of self cells becomes
significantly larger than its threshold value θ its division rate gets close to zero. For
the sake of simplicity, the natural death process of self cells is not represented in
the model, so, more accurately, (3.11) should be called the effective growth model
of self cells.
We assume that the concentration of each type of self antigens in the humoral
phase is directly proportional to the number of self cells carrying this antigen.
The case of bone marrow cells is special because it comes not only with a birth
rate, but, with given rates, bone marrow cells also produce na¨ıve B cells and Th
cells. Na¨ıve B and Th cells have randomly determined BCR and TCR shapes that
are uniformly distributed on the antigen and peptide lattices, respectively.
3.4. Danger signals and interleukins
We use the symbolic names “danger signals and interleukins” in this paper, without
specifying the exact type of these molecules, similarly to Fig. 3 of Ref. 65. These
types of soluble molecules have roles only in intermediate interactions and divisions
in the ERS model. Since conventional immune reactions correspond to the ones that
we call strong interactions and divisions, these types of molecules do not appear
when simulating CRS models.
Danger signals (soluble molecules) are emitted by B lymphocytes following dis-
ruption of homeostatic complementary interaction of B cells and Threg cells. This
process initiates an action process and also a death process of these molecules. Each
danger molecule randomly chooses a Th cell. This is a signal for the Th cell to start
intermediate type division and to secrete interleukins. Note that this danger sig-
nal is not the same as in Ref. 66 because our danger signals are emitted when the
system detects any kind of nonself and not only a dangerous one.
Interleukins are emitted by Th lymphocytes. This process initiates an action
process and also a death process of these interleukins. Each interleukin molecule
randomly chooses a B cell. This is a signal for a B cell that has lost complementary
Threg cell control to start cell division of intermediate kind.
3.5. Th cells
While different types of non-immune self cells and foreign cells (pathogens) are
treated as populations, B and Th cells are handled individually in the model. Pre-
Th cells are born in the bone marrow. The birth of a pre-Th cell initiates its own
(natural) death event, a Th cell action process and a Th cell activation control
process.
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Th cell recognition region Each Th cell has a recognition region in the peptide
lattice. If a TCR is described by the point (xT , yT ), then the corresponding recog-
nition region is a square with center (xT ,−yT ) and radius rT . The radius of the
TCR is a constant, there is no hypermutation or affinity maturation for Th cells.
The recognition region describes the potential shapes of antigens with which a TCR
can bind: the smaller the distance between a peptide (xP , yP ) located on an MHCII
and the center (xT ,−yT ) of the recognition region of the TCR, the better the fit.
Thymus To each pre-Th cell there is assigned a random event that places it into
the thymus. Here the Th cell goes under a negative and a positive selection process.
Negative selection kills pre-Th cells that are closer to one of the self-peptides than
a minimum radius rmin; negative selection occurs with a given large probability,
typically pN = 0.99.
Positive selection kills pre-Th cells that are farther from each self peptide than
a maximum radius rmax; positive selection occurs with a given, relatively smaller
probability, typically pP = 0.9. This way, some of the randomly generated Th cells
that cannot bound self-peptides may still survive and they can become infection or
mutation specific Th cells later.
The degree of maturity of a na¨ıve Th cell is 0. If a TCR is in the characteristic
ring around the reflected image of some self-peptide (see Fig. 2A), that is, rmin <
d(zP , zT ) < rmax, then it is called a regulatory Th cell and its degree of maturity is
set to 2. Here zT := (xT ,−yT ) is the center of the recognition region of the Th cell
and zP := (xP , yP ) represents the shape of a self-peptide. In our model a regulatory
Th cell has double role. On one hand, it takes part in the controlling role of the
regulatory T cell repertoire, but it can also act as a Th cell.
Other Th cells that have survived the negative and positive selections, but are
outside of the characteristic ring of each self-peptide, are called potential infection
or mutation specific Th cells, and their degree of maturity is set to 1.
When simulating a CRS model, we set rmin := rmax. Thus positive selection
and this type of regulatory Th cells are not simulated then. Care is taken that the
average number of Th cells be the same as in the case of ERS model, so the number
of potential infection specific Th cells are larger in the CRS model than in the ERS
model.
Th cell actions For each Th cell, there is a sequence of actions, with exponential
random waiting times between two actions. At each action the Th cell is to randomly
choose one of the potential target MHCII+peptide complexes in its recognition
region. The closer an MHCII+peptide complex to the center of the recognition
region, the bigger its chance of being selected.
Th cell activation control process It is a sequence of frequently occurring ran-
dom events whose purpose is to check and possibly change the state of activation
of a Th cell. A Th cell can be in a state of activated or non-activated. This process
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checks if this Th cell has received danger signal in a critical period of time before
this check. If the result of this check is “yes”, then the Th cell is set to “activated”
(stress=1); otherwise it is set to “non-activated” (stress=0).
An “activated” Th cell starts an interleukin secreting process. This process is a
signal of its activated state for “activated” B cells in its environment. We use the
symbolic names “interleukins” in this paper, without specifying the exact type of
these interleukins.
An “activated” Th cell begins cell division of intermediate kind. Division of the
intermediate kind is different from the weak or strong kind. In the CRS model we
use only division of the strong kind.
Self-nonself discrimination It is important that in the ERS model, self-nonself
discrimination is solved by the complete repertoire of Threg cells. When a regula-
tory Th cell (degree of maturity is 2) bounds with intermediate affinity a B cell’s
MHCII+peptide complex which has state “non-activated”, then with high confi-
dence it means that the peptide is a self-peptide. This contact initiates a division of
weak kind for both this regulatory Th cell and the attached B cell. This weak divi-
sion helps to stabilize this interaction among three partners: self-cells, B cells that
can react to self, and regulatory Th cells that can attach to this self-peptide with
intermediate affinity. It is important that B cells that can contact Threg cells with
all their MHCII-peptide complexes cannot start an intermediate or strong division
process. It gives the important inhibitory effect of Threg cells. This way, B cells that
react to self are in a state of “non-activated” permanently with large probability.
When a Th cell that has already went through the thymus, obtains danger
signal then it may begin a non-specific division of intermediate kind and may start
to secrete interleukins to start division of intermediate kind of activated B cells.
If a Th cell has already went through the thymus, but it is not a regulatory
Th cell (thus its degree of maturity is 1), the target is an activated B cell, and
the distance of attachment satisfies d(zP , zT ) <
rmin
2 , then with high confidence it
means that the peptide is foreign or mutated self. Here zT = (xT ,−yT ) is the center
of the recognition region of the Th cell, zP := (xP , yP ) is the point representing the
peptide, and rmin is the inner radius of the characteristic ring around the reflected
image of self-peptides. Remember that because of the negative selection, such short
distance between a self-peptide and the center of recognition region is extremely
unlikely. Then both this B cell and Th cell are very likely useful tools to fight
against an infection. As a result, this interaction may initiate a division of strong
kind both in the affected B and Th cells, plus stimulates the secretion of danger
signal (in the B cell) and interleukins (in the Th cell). Strong division of a B cell
implies its hypermutation with given probability as well. This is a direct help of the
Th cell for the affected B cell.
Th cell divisions The probability of division of a Th cell may depend on several
factors. It may get bigger when the distance d between the MHCII+peptide complex
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and the TCR is smaller (i.e., the complementarity is better). It gets smaller when
the number n0 of all TCR’s is large (i.e., the concentration of Th cells is already
large). It gets smaller when the number n1 of TCR’s in a neighborhood of the Th
cell is large (i.e., the local concentration of Th cells is already large). The formula
for the probability of division is given by a somewhat different formula for the
strong division; namely, weak and intermediate divisions do not depend on the
complementarity distance d. The reason is that weak reaction by definition have
relatively uniform distance between Threg cells and a self antigen, see the rings
of the ERS model in Fig. 2B. Also, intermediate reactions are by definition non-
specific, with almost arbitrary distance d. When simulating CRS models, we use
only strong division.
The probability of a division of weak kind of a Th cell is given by
pT,w = kw gθn0,ηn0(n0) gθn1,ηn1(n1). (3.12)
The purpose of division of weak kind is to establish a stable contact between self
antigens, B cells reacting to self with a weak affinity, and Threg cells reacting to
self peptides with an intermediate, standard affinity.
The probability of a division of intermediate kind of a Th cell is given by
pT,m = km gθn0,ηn0(n0) gθn1,ηn1(n1). (3.13)
The purpose of division of intermediate kind is to create a fast, non-specific immune
reaction to a new, typically quickly growing number of nonself antigens. The growing
amount of Th cell help (interleukins) can help the division of intermediate kind of
B cells that are able to bind the new nonself antigens in the humoral phase.
The probability of a division of strong kind of a Th cell is given by
pT,s = ks gθd,ηd(d) gθn0,ηn0(n0) gθn1,ηn1(n1). (3.14)
The purpose of division of strong kind of Th cells is to initiate a strong immune
reaction when infection or mutation specific Th cells appear and can bind infection
or mutation specific B cells. Important requirements to such a division that the
binding distance satisfy d < rmin2 and the attached MHCII be “activated”. These
requirements can guarantee with large probability that this strong reaction is not
arising against self. Then this Th cell becomes “strongly activated” (stress=2). This
condition is independent of danger signal.
For simplicity, the constants kw, km, ks above are typically set to 1.
Regulatory Th cells As we saw above, the regulatory Th cell repertoire plays a
most important controlling role in self–nonself discrimination in our ERS model.
When simulating CRS models we do not use Thregs explicitly, since their conven-
tional role is to prevent autoimmunity, and when we compare the ERS and CRS
models, autoimmunity is avoided. Their role in the ERS model is similar to the one
they have in the computational model.25 Starting in the fetus, and throughout the
entire life span, they give a faithful mirror-image of the self-peptide repertoire.
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• They regularly visit B cells having only self-peptides on their MHCII and
inhibit their strong division, but support their weak division.
• They are players in normal Th cell roles, like helping non-specific interme-
diate type and specific strong type division of B cells. They can also secrete
interleukins.
3.6. B cells
Na¨ıve B cells are born in the bone marrow. The birth of a B cell initiates its own
(natural) death event, B cell action process, and B cell activation control process,
each with separate rate. Each B cell carries a number (say, 3) of MHCII molecules.
B cell recognition region Each B cell has a recognition region in the antigen lat-
tice. If a BCR is described by the point (xB , yB), then the corresponding recognition
region is a square with center (xB ,−yB) and radius rB . The radius of the BCR of
a na¨ıve B cell is a given constant, while B cells that are born in the periphery after
hypermutation may have smaller radii. The BCR z′B = (x
′
B , y
′
B) of a hypermutated
B cell offspring is determined at random, uniformly on a square around the mother
BCR. Thus there is only a chance that its affinity to a given antigen zA = (xA, yA)
is higher, that is, the distance d(zA, z′B) is smaller than that of its mother cell. The
radius r′B of a hypermutated offspring will be smaller than that of its mother cell
depending on the above distance: r′B = c rB + r0. Typical values are c = 0.9 and
r0 = 5. This effect may increase the affinity of some “lucky” offspring to the given
antigen.
In sum, the recognition region describes the potential shapes of antigens with
which a BCR can bind: the smaller the distance between an antigen zA = (xA, yA)
and the center zB = (xB ,−yB) of the recognition region, the better the fit between
the antigen and the BCR.
B cell action process For each B cell, there is a sequence of actions, with inde-
pendent exponential waiting times between two actions. At each action the B cell
is to randomly choose one of the potential target antigens in its recognition region.
A target can be another B cell, an antibody, a non-immune self cell, or a foreign
antigen. The closer an antigen zA = (xA, yA) to the center zB = (xB ,−yB) of the
recognition region, the bigger its chance of being selected as the next target. The
chosen target can be killed only if the above distance is smaller than the recognition
radius rB of the B cell, that is, d(zA, zB) < rB . The smaller this distance, the larger
the probability that the antigen will really be destroyed. Since smaller distance
represents stronger affinity in the model, it means longer attachment between an
antigen and the BCR. So this condition is equivalent to the fact that a target can
be killed if it is bound to the BCR for a long enough time.
When the chosen target is destroyed, its peptide is placed on one of the MHCII’s
of the B cell. The MHCII selected is primarily an empty one; when all of the MHCII’s
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are already loaded, then one of them is chosen at random to replace the old peptide
by the new one.
B cell negative selection filter in the bone marrow To each na¨ıve (immature)
B cell there is assigned a random event that places it into a negative selection filter
in the bone marrow. Negative selection kills B cells that are closer to one of the
self-antigens than a minimum radius rminb; negative selection occurs with a given
large probability, typically pNb = 0.99.
The degree of maturity of a na¨ıve B cell is 0. A B cell that has survived the
negative selection is called a mature B cell, and their degree of maturity is set to 1.
Only B cells with degree of maturity ≥ 1 can function as normal B cells.
B cell activation control process In the ERS model, it is a sequence of fre-
quently occurring events whose purpose is to check and possibly change the state
of activation of a B cell. It is not used in the CRS models. The main parameter is
the critical time tcrit. Each of the MHCII carried by a B cell can be in a state of
“activated” or “non-activated”. An empty MHCII is not “activated” by definition.
• A given non-empty MHCII is set to “non-activated” when the time elapsed
since the last event effecting this MHCII is less than tcrit. Such an event can
be a regulatory Th cell attaching to this MHCII, or placing a new peptide
on this MHCII.
• A given MHCII is set to “activated” when the time elapsed since the last
event effecting this MHCII is greater than or equal to tcrit.
Similarly, a B cell can also be in a state of “activated” or “non-activated”.
• When its each MHCII is in the state of “non-activated”, the B cell itself is
set to state of “non-activated”.
• When at least one of its MHCII is “activated”, then the B cell is set to
“activated”.
An “activated” B cell starts an danger signal sending process. This process is a
signal of its activated state for Th cells in its environment.
An “activated” B cell may start a cell division of intermediate kind if it obtains
help from non-specific Th cells. Help may come as interleukins produced by Th
cells, that has arrived in a critical period of time before this check. (This kind
of cell division cannot occur with plasma cells or memory cells.) Division of the
intermediate kind is different from the weak or strong kind. Here the activation
(stress) level is 1.
In the case of cell division of the strong kind, which occurs by the help of infection
or mutation specific Th cells, the activation (stress) level is 2.
B cell division and maturity Each B cell has a degree of maturity. A na¨ıve,
immature B cell has degree 0, while B cells that have survived a negative selection
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filter in the bone marrow are mature B cells, having degree of maturity 1 first.
Mature B cells may encounter antigens at the periphery. A B cell division can
be the result of an encounter with an antigen which is escorted by a direct or
indirect (via interleukin) help from a Th cell. At each division of a B cell, one of
the two offspring inherits all characteristics of the mother cell (let us call it the
first offspring for explicitness), while the other offspring (let us call it the second
offspring) may undergo hypermutation with given probability. The first offspring
inherits the mother’s MHCII-peptide complexes, while the second offspring starts
with MHCII molecules with a default (non-specific) peptide. The second offspring
after the first division has a degree of maturity 2. The result of a hypermutation is
a B cell with randomly shaped BCR. The possible shapes are uniformly distributed
on a square of the antigen lattice, with given radius around the mother BCR.
A second division may lead to two different outcomes with given probabilities:
the second offspring can be either a memory cell (degree=3) or a plasma cell (de-
gree=4). A memory cell has the same characteristics as a normal B cell except that
its average lifespan is significantly longer (e.g 10 days instead of the standard 3
days). A plasma cell constantly – at random time instants – produces antibodies of
the type of its own BCR.
Possibility of division of a B cell arises after contacting an antigen or obtaining
Th help in the form of interleukins. The probability of division of a B cell depends
on several factors. It gets bigger when the distance d between the antigen and the
BCR is smaller (i.e., the complementarity is better), or when the radius r of the
recognition region of the BCR is smaller (i.e., the affinity of the B cell is bigger). It
gets smaller when the number n0 of other BCRs in a rectangle around the BCR is
small (i.e., the concentration of B cells is already large). Finally, one or two factors
can depend on the concentration difference c between the number of targets in the
recognition region of the B cell and the number of targets in the reflected image
of the recognition region. If the concentration difference is too small, the B cell
may get insensitive. If the concentration difference is too large, the B cell may get
anergic.
In the ERS model, the specific formulas for the probability of division in the
respective cases of weak, intermediate, and strong B cell divisions are as follows. In
the CRS models only the strong division is used. The probability of a division of
weak kind of a B cell is given by
pB,w = kw grmb+θd,ηd(d)(1− grmb−θd,ηd(d)) gθr,ηr (r) gθn,ηn(n0) (1− gnm,ηc(c)).(3.15)
The purpose of division of weak kind is to establish a stable contact between self
antigens, B cells reacting to self with a weak affinity, and Threg cells reacting to
self peptides with an intermediate, standard affinity. The first, constant factor kw
is typically 1. The purpose of the second and third factors depending on d is to
help those B cells that are at a standard distance from their targets, in the present
case, self antigens. The last factor, depending on c intends to guarantee that a
large number of antigens, typical for self antigens, be in the recognition region of
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the weakly dividing B cells. The first parameter nm here is the actual number of
bone marrow cells, which is a common measure of the size of non-immune self cell
populations.
The probability of a division of intermediate kind of a B cell is given by
pB,m = km gθd,ηd(d) gθr,ηr (r) gθn,ηn(n0) gθc2,ηc(c) (1− gθc1,ηc(c)). (3.16)
The purpose of division of intermediate kind is to create a fast, non-specific immune
reaction to a new, typically quickly growing number of nonself antigens. The growing
amount of B cells that are able to bind the new nonself antigens in the humoral
phase even when there exist no infection or mutation specific B or Th cells can give
an early start to an effective immune reaction. Activated B cells can release danger
signal to initiate a non-specific Th help as well. The value of the constant multiplier
km is typically 100 to create a fast answer to a new, quickly dividing infection.
The probability of a division of strong kind of a B cell is given by
pB,s = ks gθd,ηd(d) gθr,ηr (r) gθn,ηn(n0) gθc2,ηc(c) (1− gθc1,ηc(c)). (3.17)
The purpose of division of strong kind of B cells is to initiate a strong immune
reaction when infection or mutation specific Th cells appear and can bind infection
or mutation specific B cells. Important requirements to such a division that an
“activated” Th cell binds an “activated” MHCII of this B cell and the binding
distance between the reflected image of the TCR and the peptide is smaller than
rmin
2 . These requirements can guarantee with large probability that this strong
reaction is not arising against self. The value of the constant ks is typically 200 to
create a strong reaction when – tipically – the number of B cells specific to a new
infection is very low.
B cell affinity maturation and network memory Like in natural selection,
there exists neither intelligent control which would direct genetic mutations toward
better fit, nor memory that would save cells from genetically searching a proved
wrong “direction”. The major effect which has physiological consequences on a B
cell is the strength of antigen binding. This is like finding the source of heat in
a dark room, using a single thermometer, with no direct sensing of direction and
with no memory. The technique the present model applies is a microscopic analog
of evolution: hypermutation and selection, with survival of the fittest. Namely, the
program uses a stochastic search for best fit (or a stochastic learning process):
• An offspring may be randomly hypermutated, so a random variation is
created in the affinity to the given antigen.
• The stronger a B cell can bind a given antigen, the more offspring it can
produce.
• When the concentration of the given antigen is decreasing, a competition
arises among B cells for the antigen, and those having higher affinity would
win in this selection process.
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An affinity maturation model has to handle the danger of autoimmunity. Even
if na¨ıve Th cells which can strongly bind self peptides are deleted as a result of
negative selection in the thymus, and also na¨ıve B cells which can strongly bind
self antigens are deleted as a result of negative selection in the bone marrow, still
there is the danger that autoimmune B cell clones may be produced as a result
of hypermutation. In the presented model there is a double defense against this
danger.
• The absence of T cell help in the case of B cells that react strongly to non-
immune self antigens inhibits their division. This is an essential difference
between self and nonself in the model.
• Since nonself antigens which can start somatic hypermutation typically
appear after birth, when the number of self cells is already very large, one
can argue that at that time randomly produced self-reactive B cell clones
are confronted with an overwhelming quantity of self antigens. As a result,
these B cell clones would become anergic.67 In the model this is simulated
in the B cell division process: divisions of a B cell, see (3.16) and (3.17),
become less frequent when the number of objects in its recognition region
becomes overwhelmingly large. The reproduction process of B cells is fastest
when the concentration of the complementary antigens is neither too small,
nor too large. This is common for both self or nonself antigens in the model,
so when nonself overgrows an upper threshold, the model immune system
remains practically defenseless against it as well.
As a result of the double defense described above, there will be “holes” in the
adaptive immune system, both in the T cell and B cell populations, around the
mirror image of non-immune self cells.68,69 The negative selection in the model is
especially important during early ontogenesis when the smaller population of host
cells is vulnerable to self-reactive immune cells. As the individual reaches adult
size, the large number of host cells plus the absence of T cell help can alone inhibit
reproduction and affinity maturation of immune cells. Then negative selection in
the model (like in reality in the thymus) becomes less essential.
It is reasonable to expect that after a somatic hypermutation - affinity matura-
tion process the resulted specific B cell clones may survive for a certain period of
time as a local memory. In the model, expansion of certain B cell clones (e.g. as a
result of an infection by a foreign antigen), under favorable conditions, stimulates
the reproduction of secondary B cells which are complementary to the expanded
primary B cell clones and whose receptors are, therefore, similar to the infecting
antigens. (Of course, similarity here means a mimicry of a binding partner and not
similarity at the molecular level.) Thus a mirroring process (“ping-pong”) and a
local network memory may develop and last for a longer time, even in the absence
of the stimulating antigen. While this memory lasts, repeated infection of the same
pathogen is eliminated more efficiently. This network model of immune memory es-
sentially conforms to Jerne’s immune network concept.70 Beside other factors, like
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longer living memory cells or antigen preserving follicular dendritic cells, this could
be a possible explanation of immune memory.
3.7. Antibodies
A plasma cell is a special kind of B cells, a result of a B cell maturity process.
A plasma cell has neither a B cell action process, nor a B cell activation control
process. On the other hand, it has an antibody birth and an antibody death process.
An antibody has the same shape in the antigen lattice as the BCR of its mother
plasma cell.
Antibodies have similar action processes as B cells, but, naturally, when tagging
a target, peptide of the target does not appear on an MHCII. The complement
sub-system of the immune system is currently not represented in the model, so it is
supposed that when an antigen is tagged by an antibody, it leads to the destruction
of the targeted antigen with a certain probability.
3.8. Foreign antigens
After birth, different pathogens may enter the body, perhaps several times (e.g.
repeated infections with the same pathogen). A foreign antigen is represented by its
position (xF , yF ) in the antigen lattice and its peptide (xFP , yFP ) in the peptide
lattice. A foreign cell comes with an initial population size and a birth process with
a given initial rate (that is, with a given initial average waiting time τf0 between
divisions). If the size of the population of a specific pathogen at a certain time t is
f = f(t), then the conditional expected waiting time between two divisions in this
population is
τf =
τf0
f gθ,η(f)
=
τf0
f
(
1 +
(
f
θ
)η)
. (3.18)
For the sake of simplicity, the natural death process of foreign antigens is not repre-
sented in the model. So (3.18) should be more accurately called the effective growth
process of foreign antigens.
4. Simulation results of MistImm
In this chapter we assign specific parameter values for the MiStImm computational
model and describe the results obtained by computer simulations. MiStImm can be
initialized by approximately one hundred input parameters (Table 1 and 2.) The
parameters can be used to set various immune system models, including the above
mentioned ERS and CRS models. Once an immune system model is fixed, further
individual settings are available (for example, foreign cell injections with different
numbers or types). Different initial random numbers can be set to run different
random realizations with the same parameter settings.
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In the following, we show that a typical simulation by the ERS model fits the
basic requirements that are expected from an immune system model. Then we
compare the simulation results of the ERS and the CRS models.
4.1. Development and homeostasis of the immune system
A simulation starts from a few days after conception and goes until the 5000th time
instant; the unit of time being a tenth of a day (2 hours and 24 minutes). Initially,
only three types of non-immune self cell populations appear in the model, each
with a number of 150 cells, and no other components. Each of these populations
is accompanied by a cell division process that implies continuous growing of the
number of self cells, with decreasing rate in time (Fig. 3A). B and T cells, which
generated by the bone marrow cells, first appear at the 100th time instant (Fig. 3B).
The number of these cells also grow continuously with a decreasing rate.
Fig. 3. Development and homeostasis of the immune system. The same single simulation in bird’s
eye view (A) and a closer view (B), respectively. Horizontal axis: time (t) from conception measured
in one-tenths of a day. Vertical axis: number of cells/molecules. In the case of self cells the sum of
sizes of the self cell populations is displayed.
The peptide and the antigen lattices both have size {0, 1000}×{−500, 500}. Co-
ordinates of antigens of three different self cells (denoted by letters ‘s’) are (550, 300),
(700,−200) and (850, 150), both in the case of the peptide and the antigen lattice
(Fig. 4AB). TCR rings around the mirror images of self peptides – that are charac-
teristic features of the ERS model – begin to develop about the 1500th time instant
and become more or less stabilized by the 2800th time instant (Fig. 4A). These
rings fluctuate for two reasons: (i) occasionally global Th cell populations overgrow
the set upper limits and this reduces the probability of Th cell division; (ii) some-
times the number of presented self peptides in the MHCII-peptide complexes of B
cells reaches an extremely low level. An infection brings significant changes. A ris-
ing population of B and Th cells appear at the mirror image of the infecting agent
denoted by a letter ‘n’ (Fig. 4B).
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Table 1. The most important parameters of the MiStImm computational model. The unit of time
is one-tenth of a day: 2 hours and 24 minutes.
Parameter Description Typical value
comptype computational model 0: ERS, 1: CRS
medrepr intermediate interaction 0: off, 1: on
weakrepr weak interaction 0: off, 1: on
nrmax the simulation stops at this number of pathogens 5000
nm initial number of bone marrow cells 5
timmst starting time of the immune system 100
tmax the last time instant of the simulation 5000
xmax size of the antigen lattice 1000
r0 radius of na¨ıve B cells 140
r0s radius of spreading area of offspring B cells 60
tlifeb mean life length of a B cell 30
tlifmem mean life length of a memory B cell 150
pmem the probability of B cell changing into memory cell 0.3
thrad radius of Th cells 80
pxmax the size of the peptide lattice 1000
rminth threshold radius of negative selection 30
rmaxth threshold radius of positive selection 50
rminb threshold radius of negative selection of B cells 140
pmut the probability of B cell hypermutation at reproduction 0.4
taum mean time between two divisions of a bone marrow cell 400
taubm mean time between two births of B cells in b. marrow 30
tauselb mean time for a B cell to enter negative selection 0.05
taub mean time between two actions of a B cell 5
taubstress mean time between two B cell activation checking 0.5
taubil mean time between the births of IL type 2 0.2
taudil mean time between the deaths of IL type 2 30
tauab mean time between two actions of an antibody 0.5
taubab mean time between two births of antibodies 1
taudab mean time between two deaths of antibodies 80
tauthm mean time between two births of Th cells in b. marrow 5
tauthymus mean time for a Th cell to enter the thymus 0.05
tauth mean time between two actions of a Th cell 2
tlifeth mean life length of a Th cell 30
sreprcrit threshold radius of the strong reproduction 40
dring radius within which the cc. of Th cells are restricted 10
tcritilb crit. time between arrivals of two IL type 2 at a B cell 1
tcritth crit. time between two Th cells arrival at a given MHCII 2
tauprodil1 mean time between two births of IL type 1 0.2
taudil1 mean time between two deaths of IL type 1 30
tauil1 attack rate of an IL type 1 1
tauil attack rate of an IL type 2 1
tthcrit crit. time between arrivals of two IL type 1 at a Th cell 1
tauthstress rate of the Th activation control process 0.5
negselp threshold probability of Th negative selection 0.99
posselp threshold probability of Th positive selection 0.9
bselp threshold probability B cell negative selection 0.99
th* different theta parameters, see (3.10) 1–1000
eta* different eta parameters, see (3.10) 1–4
August 20, 2018 14:11 WSPC/INSTRUCTION FILE Mistimm
26 Szabados, Kerepesi, Baka´cs
Table 2. The important parameters of the MiStImm computational model, continued. The unit of
time is one-tenth of a day: 2 hours and 24 minutes.
Parameter Description Typical value
kth0, 1, 2 multipliers of Th reproduction, see (3.12), (3.13), (3.14) 1
kb0 multiplier of B weak reproduction, see (3.15) 1
kb1 multiplier of B intermediate reproduction, see (3.16) 100
kb2 multiplier of B strong reproduction, see (3.17) 200
nwtypes number of types of self cells 1–4
nw initial number of a specific self cell 150
xw x-coordinate of a specific self cell 0–1000
yw y-coordinate of a specific self cell -500–500
t0w starting time of a self cell type 0
tauw mean time between two divisions of a spec. self cell 40
nrtypes number of types of pathogens 1–4
nr initial number of a specific pathogen 200–700
xr x-coordinate of a specific pathogen 0–1000
yr y-coordinate of a specific pathogen -500–500
t0r starting time of a specific pathogen 3000–4000
taur mean time between two divisions of a spec. pathogen 30–80
Fig. 4. Peptide and antigen lattices in the ERS model. (A) A snapshot of the peptide lattice,
where the actual TCRs are displayed. With random ‘rings’ around the reflected images of non-
immune self antigens (‘s’) about one month after birth. A movie capturing a typical simulation
of the peptide space is available at the address https://goo.gl/QcdG48. (B) A snapshot of the
antigen lattice, where the actually existing BCRs are displayed. B cell response to a pathogen:
large density of pathogen specific B cells at the reflected image of nonself (‘n’) about one week
after the infection. As a result of negative selection, there are empty domains around the reflected
images of non-immune self antigens (‘s’). A movie capturing a typical simulation of the antigen
lattice (shape space) is also available at the address https://goo.gl/3oK1bM.
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4.2. Immune response
An immune system do not attack self cells strongly, just to a very limited extent.
Some B cells must continuously present self peptides to ensure that Threg cell char-
acteristic rings around self peptides are constantly maintained. Because of negative
selection, this type of immune response is weak and typically settles down quickly
before it becomes pathological. An immune response should have the ability to de-
stroy the majority of pathogens – some of them suddenly, others perhaps slowly,
while in some cases it may fail. In ERS model, death of an individual occurs when
the pathogen population grows up irreversibly, technically, as its size reaches 4000
cells. Diversity of pathogens are represented by different locations of their receptors,
different speeds of growth, and different initial numbers.
A normal immune response develops immune memory. Thanks to memory cells,
a second immune response against the same nonself antigen is more effective than
at a primary infection (Figure 5AB). To test this phenomenon, we have performed
500 simulations, adding the same type of pathogen (number of cells = 350, mean
waiting time between two divisions = 60) at the 3000th and at the 3150th time
instants. ERS model have won against both infections in 451 cases and the mean
time lengths needed for elimination were 62.02 (std 13.26) at the first infection and
20.51 (std 14.94) at the second infection. We have said that an elimination happened
when the number of pathogens have decreased under 50. With two-tailed t-test, the
p-value for equality of mean elimination times for the first and the second infection
was 5.2e− 227.
Experiments with our computational model showed that immune system cannot
fight effectively against more than a couple simultaneous infections. Similar is true in
the case of the development of immune memory. This observation fits experimental
results.71
Lack of negative selection of B cells results autoimmunity (Fig. 5C). Without
negative selection, some of the B cells can constantly destroy self cells.
4.3. ERS vs. CRS model
One can switch the ERS (Enhanced Role of Self ) model to a CRS (Conventional
Role of Self ) model by modifying four parameters. Turning off the division of weak
type and the division of intermediate type are required in the CRS model (medrepr
= 1 → 0 and weakrepr = 1 → 0). Turning off positive selection of T cells is also
required in the CRS model (comptype = 0 → 1). The latter adjustment causes
large growth of the T cell population, so simultaneously we need to decrease the
expectation of the waiting time between two births of T helper cells in the bone
marrow (tauthm = 5→ 30).
We compared the efficiencies of the immune reactions in the two models. Our
results showed that in the ERS model the adaptive immune reaction was able to
destroy infections with critically large initial numbers or with critically fast division
times more often than in a CRS model (Table 3 and 4). Fisher’s exact test was used
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Fig. 5. Immune response in the ERS model. (A) Normal immune response against a repeated
infection. First infection was injected at the time instant 3000 and the second infection was injected
at the time instant 3100. Both infections are the same type (number of cells = 350, mean waiting
time between two divisions = 60). The second infection was eliminated much faster because of B
cell memory. Horizontal axis: time from conception measured in one-tenths of a day. Vertical axis:
number of cells/molecules. (B) Division of weak/intermediate/strong kind of T and B cells in the
same simulation showed in (A). (C) Autoimmunity caused by the lack of negative selection of B
cells. Horizontal axis: time from conception measured in one-tenths of a day. Vertical axis: number
of cells/molecules.
for the statistical evaluation (Table 5). All the corresponding simulation results can
be seen at the address http://info.ilab.sztaki.hu/~kerepesi/MiStImm/.
Table 3. ERS vs. CRS model, simulated by MiStImm 500–500 times at various initial number of
pathogens. The unit of time is one-tenth of a day; f cells: the initial number of foreign cells at the
time instant 3000; div time: the mean waiting time between two divisions of a foreign cell; ERS
wins: number of wins of the immune system against pathogens using the ERS model setting; CRS
wins: number of wins of the immune system against pathogens using the CRS model setting; ratio:
ERS wins divided per CRS wins; p-value: one-sided p-value of the Fisher’s exact test. In every
cases ERS performed significantly better than CRS.
f cells div time ERS wins CRS wins ratio p-value
200 50 499 432 1.155 1.1E-20
250 50 497 361 1.377 1.85E-42
300 50 481 310 1.552 5.19E-45
350 50 417 225 1.853 4.48E-38
400 50 272 135 2.015 5.74E-19
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Table 4. ERS vs. CRS model, simulated by MiStImm 500–500 times at various mean waiting time
between two divisions of a pathogens. Column labels are the same as in Table 3 but the positions
of the columns “f cells” and “div time” are switched. In every cases ERS performed significantly
better than CRS.
div time f cells ERS wins CRS wins ratio p-value
40 350 208 66 3.152 1.19E-24
50 350 417 225 1.853 4.48E-38
60 350 473 320 1.478 1.16E-35
70 350 493 400 1.233 1.42E-24
80 350 500 441 1.134 2.81E-19
Table 5. Contingency table of the one sided Fisher’s exact test72 for the fourth row of Table 3. The
p-value appearing there was calculated by the formula
∑500
i=417
(642
i
)( 358
500−i
)
/
(1000
500
) ≈ 4.48E − 38.
Note that the values of the hypergeometric distribution inside the sum are the probabilities of
choosing 500 experiments out of 1000, containing exactly i ERS wins of the given 642 total number
of wins and also choosing exactly 500− i ERS losses of the given 358 total number of losses.
ERS CRS Row total
Win 417 225 642
Loss 83 275 358
Col total 500 500 1000
Data and code availability
All codes and data (including the results of the simulation) are available at http://
info.ilab.sztaki.hu/~kerepesi/MiStImm/. Every simulation result file contain
the actual parameter setting.
5. Conclusions
First we described arguments that led us to the ERS theoretical model that empha-
sizes the role of self in creating, maintaining and controlling immune responses to
self and nonself. Then we discussed the MiStImm in silico model that was made to
investigate some important characteristics of immune development, starting from
conception and ending some time after birth. Finally, results of some computer ex-
periments were discussed. An important part of the latter was the comparison of the
CRS and ERS theoretical models. We think that it is likely that evolution preferred
adaptive immune systems whose basic mechanism is closer to the ERS model than
to a CRS model, because ERS gives better results to overcome a critical primary
infection. We hope that our ideas and our computational model may encourage
investigations about the problems raised in this paper, using both in vitro and in
vivo experiments. We would especially like to see experiments clarifying questions
about self–nonself discrimination in a primary infection.
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